U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. About FDA
  3. Reports, Manuals, & Forms
  4. Reports
  5. Economic Impact Analyses of FDA Regulations
  6. Summary: Regulatory Impact Analysis of Unique Device Identification System
  1. Economic Impact Analyses of FDA Regulations

Summary: Regulatory Impact Analysis of Unique Device Identification System

This rule proposes to establish a unique device identification system to implement § 519(f) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act).  The system established by this rule would require the label of medical devices and device packages to include a unique device identifier (UDI), except where the rule provides for alternative placement of the UDI or provides an exception for a particular device or type of device such as devices sold over-the-counter and low risk devices.

The FDA is amending its July 10, 2012, proposed rule as required by Section 614 of the Food and Drug Administration Safety and Innovation Act (FDASIA).  This amendment requires modification of the timeframe for implementation of the proposed rule’s requirements as they apply to devices that are implantable, life-saving (life-supporting), or life sustaining.

 

Regulatory Impact Analysis

 

Federal Register

 

Docket

 

   
Back to Top